Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 07, 2020
ADMA Biologics announced a five-year manufacturing and supply agreement to produce and sell plasma-derived intermediate fractions from ADMA’s FDA approved Immune Globulin manufacturing process.
read more
Tuesday, January 07, 2020
Biologics Consulting announced Kenneth P. Guito, MBA was hired as its COO following a 35-year career in the Biotech/Biopharmaceutical Industry.
read more
Wednesday, January 08, 2020
Sirnaomics and Innovent Biologics announced they have entered a strategic collaboration to conduct clinical studies, using STP705 and Tyvyt.
read more
Wednesday, January 08, 2020
Alcami announced the sale of its preclinical and early stage active pharmaceutical ingredient facility in Weert, Netherlands to MercachemSyncom.
read more
Wednesday, January 08, 2020
Catalent announced the completion of the purchase of Bristol-Myers Squibb’s biologics, sterile, and oral solid dose product manufacturing and packaging facility in Anagni, Italy.
read more
Wednesday, January 08, 2020
PhoreMost has entered into a multi-project drug discovery collaboration with Boehringer Ingelheim.
read more
Wednesday, January 08, 2020
Pfenex announced that Serum Institute achieved WHO prequalification for Pneumosil, a 10-valent pneumococcal conjugate vaccine.
read more
Wednesday, January 08, 2020
MedPharm has appointed Lynn Allen as VP of Business Development.
read more
Thursday, January 09, 2020
The Clarke Companies has added Covex to its portfolio of businesses.
read more
Thursday, January 09, 2020
PPD has expanded its operations and leadership team in China to provide enhanced clinical development, laboratory, regulatory, site conduct, patient access and post-approval services for international and China-based biopharmaceutical companies.
read more
Thursday, January 09, 2020
Verastem announced a global licensing agreement with Chugai Pharmaceutical.
read more
Thursday, January 09, 2020
Gilead Sciences announced the company has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies (bNAbs) against HIV, including the two clinical-stage agents 3BNC117 and 10-1074.
read more
PhaseBio announced a financing and co-development collaboration with SFJ Pharmaceuticals to support the development of PB2452, a reversal agent for the antiplatelet therapy ticagrelor.
read more
Codexis and Nestlé Health Science have signed an agreement to advance a lead candidate discovered through a SCA into preclinical development and early clinical studies.
read more
Avid Bioservices announced the appointment of Timothy Compton as chief commercial officer.
read more